These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11520475)

  • 21. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease.
    Creese B; Da Silva MV; Johar I; Ballard C
    Expert Rev Neurother; 2018 Jun; 18(6):461-467. PubMed ID: 29764230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse risk after discontinuation of risperidone in Alzheimer's disease.
    Devanand DP; Mintzer J; Schultz SK; Andrews HF; Sultzer DL; de la Pena D; Gupta S; Colon S; Schimming C; Pelton GH; Levin B
    N Engl J Med; 2012 Oct; 367(16):1497-507. PubMed ID: 23075176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.
    Kindermann SS; Dolder CR; Bailey A; Katz IR; Jeste DV
    Drugs Aging; 2002; 19(4):257-76. PubMed ID: 12038878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 26. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
    Raskind MA; Wang LY
    Int Psychogeriatr; 2014 Jun; 26(6):879-83. PubMed ID: 24703502
    [No Abstract]   [Full Text] [Related]  

  • 27. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.
    Currier GW; Simpson GM
    J Clin Psychiatry; 2001 Mar; 62(3):153-7. PubMed ID: 11305699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease.
    Alpay M; Koroshetz WJ
    Psychosomatics; 2006; 47(1):70-2. PubMed ID: 16384811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Pipelines for Alzheimer's Disease Psychosis and Agitation.
    Oguma T; Jino K
    Chem Pharm Bull (Tokyo); 2024; 72(7):610-617. PubMed ID: 38945937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. To treat or not to treat? Managing acute symptoms in an elderly patient with Alzheimer's disease.
    Deegan R; Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2001 Oct; 39(10):12-5. PubMed ID: 11697070
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuroleptic treatment of agitation and psychosis in dementia.
    Devanand DP; Levy SR
    J Geriatr Psychiatry Neurol; 1995 Oct; 8 Suppl 1():S18-27. PubMed ID: 8561840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anticonvulsants in agitation and behavior disorders in demented subjects. Report of 8 cases].
    Fahs H; Potiron G; Senon JL; Perivier E
    Encephale; 1999; 25(2):169-74. PubMed ID: 10370890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of risperidone on behavioral and psychological symptoms associated with dementia in clinical practice.
    Kurz A; Schwalen S S; Schmitt A
    Int Psychogeriatr; 2005 Dec; 17(4):605-16. PubMed ID: 16185378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis.
    Stahl SM
    CNS Spectr; 2018 Oct; 23(5):291-297. PubMed ID: 30382934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options.
    Lesser JM; Hughes S
    Geriatrics; 2006 Dec; 61(12):14-20. PubMed ID: 17184138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of the elderly suffering from psychosis and dementia.
    Sunderland T
    J Clin Psychiatry; 1996; 57 Suppl 9():53-6. PubMed ID: 8823351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are low doses of antipsychotics effective in the management of psychomotor agitation? A randomized, rated-blind trial of 4 intramuscular interventions.
    Mantovani C; Labate CM; Sponholz A; de Azevedo Marques JM; Guapo VG; de Simone Brito dos Santos ME; Pazin-Filho A; Del-Ben CM
    J Clin Psychopharmacol; 2013 Jun; 33(3):306-12. PubMed ID: 23609398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The management of psychogeriatric patient.
    Zannino G; Gargiulo A; Lamenza F; Marotta MG; Barzotti T; Silvestri A; Ettorre E; Marigliano V
    Arch Gerontol Geriatr Suppl; 2004; (9):465-70. PubMed ID: 15207448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Longterm treatment with Risperidone in Alzheimer's disease? No justification for more "drug deaths" in nursing homes!].
    Förstl H
    Dtsch Med Wochenschr; 2013 Jan; 138(1-2):16. PubMed ID: 23250689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.